May 19, 2014
1 min read
Save

Alimera records $20.8 million net loss for first quarter

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Alimera Sciences reported a GAAP net loss of $20.8 million, or $0.58 per common share, in the first quarter of 2014, compared with a net loss of $14 million, or $0.44 per common share, in the first quarter of 2013, according to a press release.

Non-GAAP net loss was $7.1 million, or $0.20 per common share, compared with a net loss of $8.4 million, or $0.27 per common share, in 2013.

Revenue in the first quarter was $2.1 million, an increase from $935,000 in the fourth quarter of 2013.

Research and development expenses increased to $2.6 million in the first quarter of 2014, compared with $2 million in the first quarter of 2013; general and administrative expenses increased to $2.9 million from $2.7 million; and sales and marketing expenses decreased to $3.4 million from $3.6 million.